Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DYRK1A | Q13627 | 2/20 | 0.36 |
| ▸ | PIM1 | P11309 | 3/20 | 0.35 |
| ▸ | DYRK2 | Q92630 | 1/20 | 0.35 |
| ▸ | DYRK1B | Q9Y463 | 1/20 | 0.35 |
| ▸ | IMPDH2 | P12268 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17701224 | 0.70 | PIM1 (0.37) | DYRK1APIM1DYRK2DYRK1BIMPDH2 | |
| SCHEMBL8052675 | 0.68 | MAPT (0.39) | MAPT | |
| SCHEMBL571374 | 0.67 | HDAC8 (0.50) | DYRK1APIM1DYRK2DYRK1BIMPDH2 | |
| SCHEMBL990825 | 0.67 | CYP2A6 (0.39) | PIM1 | |
| SCHEMBL17701217 | 0.67 | DYRK1A (0.46) | DYRK1APIM1DYRK2DYRK1BMAPT | |
| SCHEMBL17701239 | 0.67 | CD38 (0.32) | HDAC8 | |
| SCHEMBL17701204 | 0.66 | DYRK1A (0.41) | DYRK1ADYRK2DYRK1BMAPTHDAC8 | |
| SCHEMBL29796804 | 0.66 | MAPT (0.40) | DYRK1APIM1DYRK2DYRK1BIMPDH2 | |
| SCHEMBL22895342 | 0.66 | PIM1 (0.38) | DYRK1APIM1DYRK2DYRK1BIMPDH2 | |
| SCHEMBL943994 | 0.65 | NISCH (0.39) | PIM1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160118598-A1 | ELECTRON TRANSPORT MATERIAL AND ORGANIC ELECTROLUMINESCENT DEVICE USING SAME | JNC CORPORATION (JP) | 2016-04-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160118598-A1 | ELECTRON TRANSPORT MATERIAL AND ORGANIC ELECTROLUMINESCENT DEVICE USING SAME | HVCN1, VDAC1, SLC26A3 | DYRK1A 3602/4885PIM1 2642/4885DYRK2 3520/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.